CINCOR PHARMA INC (CINC)

US17240Y1091 - Common Stock

29.06  -0.14 (-0.48%)

After market: 29.25 +0.19 (+0.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.00
Operating Expenses
82.53M42.51M21.13M5.14M
Research and Development
55.94M21.51M17.95M3.93M
Selling, General, and Administrative Expenses
26.59M21.00M3.17M1.21M
Operating Income
-82.53M-42.51M-21.13M-5.14M
Interest Income/Expense
-5.56M-7.86M-1.17M101.71K
Income Before Taxes
-88.09M-50.37M-22.30M-5.04M
Net Income
-88.09M-50.37M-22.30M-5.04M
 
Per Share Data
EPS Diluted Total Ops
-2.38-1.38-0.61-0.14
Non GAAP EPS
-17.28N/AN/AN/A
 
Statistics

All data in USD

Charts